Clinical Trial 42459

share

Woodstock, GA 30189


Study Summary:

28-day study for women experiencing acute symptoms of  urinary tract infection (UTI). This is a phase 3, randomized, double-blind study of the efficacy, tolerability, and safety of oral sulopenum etzadroxil/probenecid versus oral coprofloxacin for treatment of uncompicated urinary tract infections in adult women.


Qualified Participants Must:

• Be female
• be age 18+
• have 2 or more symptoms: urinary frequency, urinary urgency, pain or burning upon urination, suprapubic pain
• onset of symptoms within the past 24-72 hours


Qualified Participants May Receive:

Urinalysis at screening; treatment of confirmed UTI with investigational product or ciprofloxacin; compensation for time/travel


Study is Available At:

North Georgia Clinical Research
1192 Buckhead Crossing, Suite A
Woodstock, GA 30189
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 25 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.